B. Riley Wealth Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

B. Riley Wealth Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-34,650	Closed	-$457K	–	1319
2025 Q1	$457K	Sell	34,650 -22,700	-40%	-$313K	0.01%	800
2024 Q4	$906K	Buy	57,350 +26,500	+86%	+$398K	0.03%	481
2024 Q3	$490K	Buy	+30,850	New	+$496K	0.01%	747
2021 Q3	–	Sell	-61,700	Closed	-$908K	–	1457
2021 Q2	$908K	Buy	61,700 +14,000	+29%	+$196K	0.03%	544
2021 Q1	$586K	Buy	+47,700	New	+$613K	0.02%	658
2015 Q1	–	Sell	-40	Closed	–	–	1661
2014 Q4	$0	Buy	+40	New	+$421	﹤0.01%	3736
2014 Q3	–	Sell	-40	Closed	-$361	–	1606
2014 Q2	$361	Buy	+40	New	+$336	﹤0.01%	2354

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

B. Riley Wealth Advisors's RDY Position: Q2 2025 in Review

B. Riley Wealth Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q2 2025, closing a stake of 34,650 shares — an estimated $457K sold.

B. Riley Wealth Advisors first reported a position in RDY in Q2 2014 and held it in 7 quarters. The position peaked at $908K in Q2 2021. 243 funds tracked by Wall St. Rank hold RDY as of Q2 2025.

B. Riley Wealth Advisors reported no remaining Dr. Reddy's Laboratories position as of Q2 2025 after selling out during the quarter.
B. Riley Wealth Advisors sold 34,650 Dr. Reddy's Laboratories shares in Q2 2025, an estimated $457K.
B. Riley Wealth Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2014 and held it in 7 quarters.
B. Riley Wealth Advisors's Dr. Reddy's Laboratories position peaked at $908K in Q2 2021.
243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2025.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2025, filed 19 Aug 2025.